#1 Rated Biotech Analyst on the Sell-Off By: CNBC.com News February 08, 2016 at 16:09 PM EST Amid a sharp sell-off in the Biotech sector, Evercore ISI's Mark Schoenebaum weighs in on if the sector has seen bottom Read More >> Related Stocks: Amgen Nasdaq Biotechnology Ishares ETF